Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine hippurate vs antibiotic prophylaxis for recurrent urinary tract infections in women
2025-523922-42-00Phase 4Authorised
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methenamine hippurate in urinary tract infection (UTI) (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Primary clinical variable and Primary microbiological variable. Planned start Mar 2026; status: authorised.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2025-523922-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523922-42-00.